Mitochondrial Thioredoxin: novel regulator for NADPH oxidase and angiotensin II-induced hypertension.
Fukai
Tohru
T
D000804:Angiotensin II / Q000009:adverse effects* / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004195:Disease Models, Animal; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D051379:Mice; D008822:Mice, Transgenic; D008928:Mitochondria / Q000378:metabolism; D019255:NADPH Oxidases / Q000187:drug effects / Q000378:metabolism*; D011897:Random Allocation; D017382:Reactive Oxygen Species / Q000378:metabolism; D012680:Sensitivity and Specificity; D013879:Thioredoxins / Q000187:drug effects / Q000378:metabolism*
D017382:Reactive Oxygen Species; D000804:Angiotensin II; D013879:Thioredoxins; D019255:NADPH Oxidases